PINC Stock - Premier, Inc.
Unlock GoAI Insights for PINC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.01B | $1.14B | $1.10B | $1.43B | $1.72B |
| Gross Profit | $743.36M | $867.12M | $877.25M | $885.04M | $837.33M |
| Gross Margin | 73.4% | 76.3% | 80.1% | 61.8% | 48.6% |
| Operating Income | $1.12M | $126.65M | $244.13M | $260.07M | $256.92M |
| Net Income | $20.27M | $119.54M | $175.03M | $265.87M | $287.52M |
| Net Margin | 2.0% | 10.5% | 16.0% | 18.6% | 16.7% |
| EPS | $0.22 | $1.05 | $1.47 | $2.21 | $2.24 |
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; STOCKD, an e-commerce platform; PROVIDEGX program, which identifies supply sources for drugs that are on or may be at risk of being added to the national drug shortage list, or that are vulnerable to pricing volatility, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company also provides services to other businesses, including food service, schools, and universities. Premier, Inc. was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 26th 2024 | The Benchmark Company | Downgrade | Hold | - |
| May 8th 2024 | Canaccord Genuity | Downgrade | Hold | $21← $27 |
| February 26th 2024 | Leerink Partners | Initiation | Market Perform | $22.5 |
| January 3rd 2024 | Barclays | Initiation | Equal Weight | $22 |
| August 23rd 2023 | Piper Sandler | Downgrade | Neutral | $25← $44 |
| May 3rd 2023 | Robert W. Baird | Downgrade | Neutral | $30← $43 |
| May 2nd 2023 | Raymond James | Downgrade | Market Perform | - |
| January 27th 2023 | Credit Suisse | Upgrade | Neutral | $38 |
| November 2nd 2022 | Robert W. Baird | Upgrade | Outperform | $41 |
| May 4th 2022 | Piper Sandler | Upgrade | Overweight | $45← $39 |
| April 14th 2022 | Guggenheim | Initiation | Neutral | - |
Earnings History & Surprises
PINCEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 4, 2025 | $0.28 | $0.30 | +7.1% | ✓ BEAT |
Q3 2025 | Aug 19, 2025 | $0.34 | $0.46 | +35.3% | ✓ BEAT |
Q2 2025 | May 6, 2025 | $0.31 | $0.44 | +41.9% | ✓ BEAT |
Q1 2025 | Feb 4, 2025 | $0.29 | $0.27 | -6.9% | ✗ MISS |
Q4 2024 | Nov 5, 2024 | $0.26 | $0.34 | +30.8% | ✓ BEAT |
Q3 2024 | Aug 20, 2024 | $0.49 | $0.69 | +40.8% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.47 | $0.55 | +17.0% | ✓ BEAT |
Q1 2024 | Feb 5, 2024 | $0.54 | $0.60 | +11.1% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.45 | $0.54 | +20.0% | ✓ BEAT |
Q3 2023 | Aug 22, 2023 | $0.67 | $0.68 | +1.5% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $0.58 | $0.58 | 0.0% | = MET |
Q1 2023 | Feb 7, 2023 | $0.67 | $0.72 | +7.5% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $0.57 | $0.52 | -8.8% | ✗ MISS |
Q3 2022 | Aug 16, 2022 | $0.60 | $0.61 | +1.7% | ✓ BEAT |
Q2 2022 | May 3, 2022 | $0.57 | $0.57 | 0.0% | = MET |
Q1 2022 | Feb 1, 2022 | $0.65 | $0.73 | +12.3% | ✓ BEAT |
Q4 2021 | Nov 2, 2021 | $0.61 | $0.64 | +4.9% | ✓ BEAT |
Q3 2021 | Aug 17, 2021 | $0.60 | $0.59 | -1.7% | ✗ MISS |
Q2 2021 | May 4, 2021 | $0.55 | $0.64 | +16.4% | ✓ BEAT |
Q1 2021 | Feb 2, 2021 | $0.55 | $0.65 | +18.2% | ✓ BEAT |
Latest News
Upwork Inc. Will Replace Premier Inc. In The S&P SmallCap 600 Effective Prior To The Open Of Trading On Friday, November 28
📈 PositivePremier Shareholders Approve Proposed Acquisition By Patient Square Capital Affiliate At $28.25/Share
📈 PositivePiper Sandler Maintains Neutral on Premier, Raises Price Target to $28.25
➖ NeutralPremier Withdraws Fiscal 2026 Guidance Following Definitive Agreement To Be Acquired By Patient Square Capital Affiliate
➖ NeutralPremier Q1 Adj. EPS $0.30 Beats $0.27 Estimate, Sales $240.004M Miss $240.874M Estimate
📈 PositiveUBS Maintains Neutral on Premier, Raises Price Target to $28.25
➖ NeutralPremier shares are trading higher after the company announced a definitive agreement to be acquired by Patient Square Capital.
📈 PositivePremier to be acquired by Patient Square Capital in $2.6B deal
📈 PositivePremier, Inc. To Be Acquired By Patient Square Capital In Definitive $2.6B Cash Deal At $28.25 Per Share
📈 PositivePremier Enters A Five-Year Group Purchasing Agreement With Premier Infusion And Healthcare Services; The Five-Year Agreement Supports Premier Infusion And HCS's Continued Growth In The Outpatient Infusion Market
📈 PositivePiper Sandler Maintains Neutral on Premier, Raises Price Target to $28
➖ NeutralB of A Securities Maintains Underperform on Premier, Raises Price Target to $21
➖ NeutralLeerink Partners Maintains Market Perform on Premier, Raises Price Target to $26
➖ NeutralPremier shares are trading higher after the company reported better-than-expected Q4 financial results.
📈 PositiveCorrection: Premier Sees FY2026 Adj EPS $1.33-$1.43 vs $1.39 Est; Sees Sales $940.000M-$1.000B vs $991.463M Est
➖ NeutralPremier Sees FY2026 Adj EPS $1.37-$1.43 vs $1.39 Est; Sees Sales $955.000M-$995.000M vs $991.463M Est
➖ NeutralPremier Q4 Adj. EPS $0.43 Beats $0.34 Estimate, Sales $262.857M Beat $247.682M Estimate
📈 PositiveFrequently Asked Questions about PINC
What is PINC's current stock price?
What is the analyst price target for PINC?
What sector is Premier, Inc. in?
What is PINC's market cap?
Does PINC pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PINC for comparison